Literature DB >> 6245395

Treatment of metastatic trophoblastic disease with poor prognosis.

E A Surwit, C B Hammond.   

Abstract

Fifty-one patients are presented who were treated for poor-prognosis gestational trophoblastic disease by physicians at Duke University Medical Center (Southeastern Regional Trophoblastic Disease Center) between 1968 and 1978. Disease in 72% (37 of 51 patients) is currently in remission (8 months to 10 years). Treatment was primarily by multiagent chemotherapy, with adjunctive surgery and radiation therapy in selected patients. Unsuccessful chemotherapy prior to treatment at this center, a prolonged interval from the antecedent pregnancy to treatment, and liver metastases portended a worse prognosis in these patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245395

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  A translocator protein ligand PK11195 shows antigrowth activity in human choriocarcinoma cells.

Authors:  Noriyuki Takai; Naoko Kira; Terukazu Ishii; Toshie Yoshida; Masakazu Nishida; Yoshihiro Nishida; Kaei Nasu; Masayuki Takano; Haruna Midori; Satoko Koga; Hisashi Narahara
Journal:  Tumour Biol       Date:  2012-04-20

2.  Metastatic intracerebral choriocarcinoma in a teenager.

Authors:  G W Chapman
Journal:  J Natl Med Assoc       Date:  1997-11       Impact factor: 1.798

3.  Erucylphosphocholine induces growth inhibition, cell cycle arrest, and apoptosis in human choriocarcinoma cells.

Authors:  Noriyuki Takai; Tami Ueda; Terukazu Ishii; Naoko Kira; Masakazu Nishida; Kaei Nasu; Hisashi Narahara
Journal:  Tumour Biol       Date:  2011-01-08

4.  [Bone metastasis for choriocarcinoma].

Authors:  S Baklouti; M H Elleuch; M H Kammoun; S Sellami
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

Review 5.  The detection and evaluation of human tumor metastases.

Authors:  D J Laurence; A M Neville
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

6.  Calcium/calmodulin-dependent kinase inhibitor induces growth inhibition, cell cycle arrest, and apoptosis in human choriocarcinoma cells.

Authors:  Noriyuki Takai; Tami Ueda; Naoko Kira; Terukazu Ishii; Toshie Yoshida; Satoko Koga; Masakazu Nishida; Kaei Nasu; Hisashi Narahara
Journal:  Tumour Biol       Date:  2012-01-31

7.  Epigenetic therapy in human choriocarcinoma.

Authors:  Noriyuki Takai; Hisashi Narahara
Journal:  Cancers (Basel)       Date:  2010-09-10       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.